By Brazil Stock Guide – Hapvida Participações e Investimentos S.A. (B3: HAPV3) announced a new share buyback program for up to 70 million shares, a move that follows a dramatic 43.13% plunge in its stock price on Thursday, driven by the market’s negative reaction to its weak third-quarter 2025 (3Q25) results. The stock closed the session at R$18.59.
The company’s executive board will determine the timing and volume of the acquisitions, authorized to reach up to 70,000,000 shares over an 18-month period starting November 13, 2025. The purchases will be executed on the B3 exchange at market prices through intermediary financial institutions, including Bank of America Merrill Lynch, BTG Pactual, Bradesco, Itaú, and XP Investimentos.
“This buyback program underscores our firm belief in the company’s long-term value and is a clear action to capitalize on what we see as a significant disconnect between the market price and the intrinsic value of Hapvida,” said CFO, Investor Relations and Technology Officer, Luccas Augusto Adib.
The buyback initiative comes as a direct response to a severe market rout, placing Hapvida at the center of investor concerns regarding the competitive and cost pressures in the Brazilian healthcare sector. The company’s disappointing quarterly figures likely heightened anxieties about margin erosion and growth sustainability in the industry.
Following the historic single-day drop, the buyback announcement aims to stabilize the stock and restore investor confidence. The shares are now under intense scrutiny after this severe correction.
The market will now focus on the execution of the buyback and any forthcoming details from management on its strategy to address the operational challenges highlighted in the 3Q25 report. The minutes from the Board of Directors’ meeting approving the program are available on the company’s investor relations website.
Leave a Reply